Search Login Register

bismuth tripotassium dicitrate (bismuth subcitrate) Summary

Description: contains tripotassium di-citratobismuthate used in gastric & duodenal ulcer therapy; do not confuse with colloidal bismuth subnitrate

Also Known As: bismuth subcitrate; Armstrong brand of bismuth tripotassium dicitrate; Bi-citrate; Biselic; Bismofarma Show All >>

Networked: 311 relevant articles (48 outcomes, 64 trials/studies) for this Bio-Agent

Key Diseases for which bismuth tripotassium dicitrate is Relevant

  1. Ulcer : 16 outcomes 21 studies in 73 results
  2. Duodenal Ulcer (Curling's Ulcer) : 12 outcomes 24 studies in 91 results
  3. Stomach Ulcer (Gastric Ulcer) : 9 outcomes 7 studies in 27 results
  4. Peptic Ulcer (Peptic Ulcers) : 8 outcomes 6 studies in 59 results
  5. Infection : 8 outcomes 5 studies in 70 results
Show All >>

Drugs Related to bismuth tripotassium dicitrate

  1. bismuth tripotassium dicitrate (bismuth subcitrate)
  2. Cimetidine (Biomet)
  3. Metronidazole (Metric)
  4. Amoxicillin (Wymox)
  5. Omeprazole (Esomeprazole)
  6. Ranitidine (Zantac)
  7. Sucralfate (Carafate)
  8. Tetracycline (Achromycin)
  9. Famotidine (Pepcid)
  10. Clarithromycin (Biaxin)
Show All >>

Therapies Related to bismuth tripotassium dicitrate

  1. Enema (Enemas)
  2. Aftercare (After-Treatment)
  3. Salvage Therapy
  4. Oral Administration

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.